Semaglutide is generally well tolerated with similar dropout fees when compared with placebo, although it may very well be significantly less perfectly tolerated than dulaglutide (Trulicity).1,3 The most common adverse outcomes are nausea, vomiting, and diarrhea and may be experienced by about 30% of patients, commonly in the event the dose is grea